pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
Companies
by activity
Most Active
Biggest Pipelines
Recently Active
hiring
Companies Hiring Now
Big Pharma Roles
All Companies →
Drugs & Pipeline
intelligence
Drugs
Patent Cliff
research
Publications
Topics
Calendar
window
Next 90 Days
All (incl. Past)
by type
PDUFAs
Approvals
Earnings
Readouts
◐
Sign In
Subscribe
🐶
home
jobs
news
cal
search
the cabinet
Drugs
8,127
products tracked ·
1,561
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
MP-1032
Coronavirus Disease 2019 (COVID-19)
MetrioPharm AG
0
catalysts
Phase 2
MPB-1734
Solid Tumor
MegaPro Biomedical Co Ltd
0
catalysts
Phase 2
MRG-002
Gastric Cancer
Shanghai Miracogen Inc
0
catalysts
Phase 2
MRG-004A
Solid Tumor
Shanghai Miracogen Inc
← prev
page 19 of 53
next →
131
Pain
89
Neurology
1
0
catalysts
Phase 2
MRM-3379
Fragile X Syndrome
$MIRM
Mirum Pharmaceuticals, Inc.
0
catalysts
Phase 2
MRT-2359
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$GLUE
Monte Rosa Therapeutics, Inc.
0
catalysts
Phase 2
MT-125
Glioblastoma Multiforme (GBM)
Myosin Therapeutics Inc
0
catalysts
Phase 2
MT-2990
Endometriosis
Tanabe Pharma Corp
0
catalysts
Phase 2
MTG-201
Prostate Cancer
Momotaro-Gene Inc
0
catalysts
Phase 2
MTL-CEBPA
Hepatocellular Carcinoma
Mina Therapeutics Ltd
0
catalysts
Phase 2
MTX-001
Venous Leg Ulcers (Crural Ulcer)
Merakris Therapeutics Inc
0
catalysts
Phase 2
MTX-463
Idiopathic Pulmonary Fibrosis
Eli Lilly and Co
0
catalysts
Phase 2
MTX-652
Acute Renal Failure (ARF) (Acute Kidney Injury)
Mission Therapeutics Ltd
0
catalysts
Phase 2
MVAmBN-396
Eastern Equine Encephalitis
Bavarian Nordic AS
0
catalysts
Phase 2
MVCCOV-1901
Coronavirus Disease 2019 (COVID-19)
Medigen Vaccine Biologics Corp
0
catalysts
Phase 2
MVRT-3011
Recurrent Head And Neck Squamous Cell Carcinoma
Immvira Co Ltd
0
catalysts
Phase 2
MVX-220
Angelman Syndrome
Mavrix Bio LLC
0
catalysts
Phase 2
MWTx-01
Polycythemia Vera
$IRON
Disc Medicine, Inc.
0
catalysts
Phase 2
MZ-1866
Unspecified Genetic Disorders
Mahzi Therapeutics Inc
0
catalysts
Phase 2
MaaT-013
Graft Versus Host Disease (GVHD)
MaaT Pharma SA
0
catalysts
Phase 2
MesenCure
Acute Respiratory Distress Syndrome
Bonus BioGroup Ltd
0
catalysts
Phase 2
MesoCancerVac
MesoPher
Malignant Mesothelioma
Amphera BV
0
catalysts
Phase 2
Motrem
Septic Shock
Triggering receptor expressed on myeloid cells 1
Inotrem SA
0
catalysts
Phase 2
Mydicar
Systolic Heart Failure (HFrEF)
Sardocor Corp
0
catalysts
Phase 2
N-acetyl cysteine amide
Retinitis Pigmentosa (Retinitis)
Nacuity Pharmaceuticals Inc
0
catalysts
Phase 2
NA-704
Amyotrophic Lateral Sclerosis
Biomed Industries Inc
0
catalysts
Phase 2
NA-931
Obesity
Biomed Industries Inc
0
catalysts
Phase 2
NB-001
DiGeorge Syndrome
Nobias Therapeutics Inc
0
catalysts
Phase 2
NB-003
Gastrointestinal Stromal Tumor (GIST)
NewBay Medical Technology Co Ltd
0
catalysts
Phase 2
NBM-BMX
Metastatic Uveal Melanoma
Novelwise Pharmaceutical Corp
0
catalysts
